Home

JOSHUA S BOGER

CIK 1197023 · CEO · last filed 2026-06-15

JOSHUA S BOGER is a CEO who has filed 317 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $3.0M of CRVO on Jun 15, 2026. Across all open-market trades the lifetime net is −$169.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $158.5M across reported positions. 314 SEC filings were submitted jointly with VERTEX PHARMACEUTICALS INC / MA.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$158.45M

Companies

2

Total Filings

317

Lifetime Open-Market Net

-$169.35M

Filer Profile

Reported Address
130 WAVERLY STREET
CAMBRIDGE, MA 02139
Related Filers
VERTEX PHARMACEUTICALS INC / MA — 314 joint filings, latest 2017-06-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRVO Director 2,012,682 $2.57 $5.17M $3.00M 6 2026-06-15
VRTX Director 297,374 $515.44 $153.28M -$172.35M 311 2017-06-09

Recent Filings

317 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 CRVO Buy (P) +955,414 $3.00M EDGAR
2026-06-10 CRVO Grant (A) — $0 EDGAR
2025-06-25 CRVO Grant (A) — $0 EDGAR
2024-06-14 CRVO Grant (A) — $0 EDGAR
2024-02-28 CRVO Mixed +495,959 $0 EDGAR
2024-02-13 CRVO Grant (A) — $0 EDGAR
2017-06-09 VRTX Exer (M) +2,941 $0 EDGAR
2017-06-05 VRTX Mixed −753 $0 EDGAR
2017-01-13 VRTX Mixed — -$369.4K EDGAR
2017-01-06 VRTX Mixed — -$265.4K EDGAR
Showing 1–10 of 317
Page 1 of 32
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.